Records containing: Major Depressive Disorder
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study results posted · 2026-10-30SMART Trial to Predict Anhedonia Response to Antidepressant Treatment
-
CLINICAL_TRIALS study results posted · 2026-10-29An Open Label Study of Single-Dose Psilocybin for Major Depressive Disorder With Co-occurring Borderline Personality Disorder
-
CLINICAL_TRIALS study record update · 2026-10-27A Phase III, Placebo-Controlled, Randomized, Double-Blind Trial of Oral Doses of CYB003 to Assess Combined Safety and Efficacy in Humans With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2026-10-13A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study to Evaluate Azetukalner in Moderate-to-Severe Major Depressive Disorder
-
CLINICAL_TRIALS study results posted · 2026-10-08Elucidating the Neurocircuitry of Irritability With High-Field Neuroimaging to Identify Novel
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study results posted · 2026-09-29Randomized, Cross-over, Placebo-controlled Trial to Determine Target Engagement and Dose Response of Optimized Closed-loop rTMS for Medication-resistant Depression
-
CLINICAL_TRIALS study results posted · 2026-09-28Pilot Study Using Endogenous Aperiodic Brain Activity to Personalize Transcranial Alternating Current Stimulation as a Treatment for Antenatal Depression: PandA-tACS
-
CLINICAL_TRIALS study record update · 2026-09-28A Phase III, Placebo-Controlled, Randomized, Double-Blind Trial of Oral Doses of CYB003 to Assess Combined Safety and Efficacy in Humans With Major Depressive Disorder
-
CLINICAL_TRIALS study results posted · 2026-09-21A Proof-of-Concept, Randomized, Double-blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 in Major Depressive Disorder
-
CLINICAL_TRIALS study results posted · 2026-09-01An Open-Label Study Evaluating the Safety and Efficacy of Ropanicant in Participants With Moderate to Severe Major Depressive Disorder
-
CLINICAL_TRIALS study results posted · 2026-08-13Sex-Dependent Impact of Transcutaneous Vagal Nerve Stimulation on the Stress Response Circuitry and Autonomic Dysregulation in Major Depression
-
CLINICAL_TRIALS study record update · 2026-08-12A Phase III, Placebo-Controlled, Randomized, Double-Blind Trial of Oral Doses of CYB003 to Assess Combined Safety and Efficacy in Humans With Major Depressive Disorder
-
CLINICAL_TRIALS study results posted · 2026-07-30ActiveCBT for Depression: Transforming Treatment Through Exercise Priming
-
CLINICAL_TRIALS study results posted · 2026-07-15CRCNS US-France Research Proposal: Probing the Dorsolateral Prefrontal Cortex and Central Executive Network for Improving Neuromodulation in Depression
-
CLINICAL_TRIALS study results posted · 2026-07-10A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- Controlled Study to Assess the Efficacy and Safety of REL-1017 as Adjunctive Treatment of Major Depressive Disorder (The RELIANCE-II Study)
-
CLINICAL_TRIALS study results posted · 2026-07-10A Randomized, Double-Blind, Placebo-Controlled Trial of REL-1017 as an Adjunctive Treatment for Major Depressive Disorder (RELIGHT)
-
CLINICAL_TRIALS study record update · 2026-07-06A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2026-07-06A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder
-
CLINICAL_TRIALS study results posted · 2026-06-23Transdiagnostic Brain-Behavior Profiling to Enhance Cognitive Behavioral Therapy Response
-
CLINICAL_TRIALS study record update · 2026-06-09Long-term Study to Assess the Safety and Effectiveness of NMRA-335140 in Participants With Major Depressive Disorder
-
CLINICAL_TRIALS study results posted · 2026-04-29The Effects of Videogames on Depression Symptoms and Brain Dynamics
-
CLINICAL_TRIALS study record update · 2026-04-27Rapid Antidepressant Dynamics in Acute Neuromodulation Treatments
-
CLINICAL_TRIALS study record update · 2026-04-24The Effect of Celecoxib on Neuroinflammation in MDD: PET Imaging of a Novel Treatment Target With [18F]FEPPA
-
CLINICAL_TRIALS study record update · 2026-04-24Study of Neuro-Cognitive Correlates of Pediatric Anxiety Disorders
-
CLINICAL_TRIALS study record update · 2026-04-24Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder